By Kong Khoo
Cancer Drug Access
Please note that the NOPS Presentations are not edited. If you experience any difficulties with the recorded presentations, please send an email to info@capho.org.
By Kong Khoo
Cancer Drug Access
By Danica Lister
By Rick Abbott
Baxter Satellite Symposium: “Collaborating for Chemo… A Coast to Coast Perspective”
Meeting of the Minds – Pharmacy Services and Integration
Beyond Temozolomide: Treating CNS Tumours by Karen Levac
Intraperitoneal Chemotherapy for Ovarian Cancer by Lisa Rambout, RPh, BSc Phm, ACPR
By Anne Katz
By Tejinder Bains, Pediatric Oncology Pharmacist, Children's Hospital of Eastern Ontario, Ottawa, ON and Geneviève Goulet, Pediatric Oncology Pharmacist, Children's Hospital of Eastern Ontario, Ott
By Joel Gingerich
By Chaim Shustik
By Mari Culotta-Mascioli
By Michael Leung
Challenges & Solutions
Presenter: George Dranitsaris, M.Pharm., FCSHP, Research Pharmacist
The Double-Edged Sword - How can a drug be a life saver and potentially fatal at the same time? Drug Interactions in Oncology by Scott Edwards, Clinical Oncology Pharmacy Specialist, Dr.
By Carlo De Angelis, Clinical Pharmacy Coordinator, Sunnybrook & Women's Health Sciences Centre, Toronto, ON
Outline:
By Jennifer Jeon
By Larry Broadfield
By Nathalie Letarte
By Dana Cole, CAPhO President, Interim Regional Director - Pharmacy Services, Northern Health, Prince George, BC and Lee Gordon, Lethbridge Cancer Center, Lethbridge, AB
Outline:
By Carole Chambers, ISOPP President, Alberta Health Services - Pharmacy Director, Cancer Services, Tom Baker Cancer Centre, Calgary, AB
Objectives:
By Heidi Schulz, Technical Co-ordinator, Cross Cancer Institute, Edmonton, AB
Objectives:
By Pierre Laneuville
Full title: Lenalidonide (Revlimid) - A New Treatment Option in Myelodysplastic Syndrome and Multiple Myeloma
By Sylvia Hyland, Institute for Safe Medication Practices and Andrea Cassano-Piche, Healthcare Human Factors Group, University Health Network
By Nathalie Letarte, Oncology Pharmacist, Pharmacy Department CHUM, Clinical Professor at the Pharmacy Faculty from the University of Montreal, Montreal, QC
Oral Sessions - Award Winning Posters
By Paul Perreault and Jodi Walker-Tweed
By Karen MacCurdy Thompson, Oncology Pharmacist, The Moncton Hospital, Moncton, NB
By Martin Franco, Pharmacien, Secteur Hémato-Oncologie, Greffe de Cellules Hématopoïétiques, Hôpital Maisonneuve-Rosemont, Montréal, QC
By Darryl Boehm, Provincial Manager, Oncology Pharmacy Services, Saskatchewan Cancer Agency c/o Allan Blair Cancer Centre, Regina, SK
By Jamie Trudel, Pharmacy Technician, CancerCare Manitoba, Winnipeg, MB
By Dave Tremblay
CAPhO Poster Award Announcement
The Question Period from "Break'in a New Trail"
followed by
See What the Future has in Store by Jeff Barnett, BC Cancer Agency, Victoria, BC
Agenda:
By Dr. Robert Dorr, Professor of Pharmacology, College of Medicine, and Director, Pharmacology Research Program, Arizona Cancer Center, Tucson, AZ, USA
Surface Decontamination:
By Kelly Ann Wakeford, Senior Pharmacy Technician, Juravinski Cancer Centre, Hamilton, ON
Objectives:
By Sobair Osmanzai
By Kevin Zbuk
By Carlo De Angelis (Continued)
Followed by:
Annual General Meeting 2008 including:
By Sheri Dyck
By Lori Gagnon, Pharmacist, Cross Cancer Institute
(Note: the break is recorded so the presentation starts several minutes into the recording)
By Debbie Milliken
By Alison Chambers
Objectives:
By Mona Sabharwal, Senior Manager, Drug Benefits Management, Ontario Public Drug Programs, Ministry of Health and Long Term Care, Toronto, ON
Objectives:
By Tim Fleming, President and CEO, Canadian Association of Pharmacy Technicians, Mississauga, ON
Pharmacy Technicians: To regulate or not to regulate
Vitamin D: A Ray of Hope for Cancer? by Cheri Van Patten
Targeting Therapies - The Changing Toxicity Profile of Cancer Related Therapies - Carlo De Angelis
Objectives
Includes information from NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings" recommendations and are current to 2004
7th Ed., 2004. Vincent T. Devita, Ed
Comprehensive, in-depth coverage of almost every aspect of cancer
7th Ed., 2004. Vincent T. Devita, Ed
Comprehensive, in-depth coverage of almost every aspect of cancer
6th Ed, 2007. Dominic A. Solimando
January 14, 2011
Full Study Report and Recommendations
January 14, 2011
Version 1.0
NOPS 2003 Onsite Program, on overview of the program by day with presenters
NOPS 2004 Onsite Program, on overview of the program by day with presenters
NOPS 2005 Onsite Program, on overview of the program by day with presenters
NOPS 2006 Onsite Program, on overview of the program by day with presenters
NOPS 2007 Onsite Program, on overview of the program by day with presenters
NOPS 2008 Onsite Program, on overview of the program by day with presenters
NOPS 2009 Onsite Program, on overview of the program by day with presenters
NOPS 2010 Onsite Program, on overview of the program by day with presenters
The NOPS 2011 Program includes the following slide presentations:
George Dranitsaris
Biosimilars of Protein Based Drugs: Current Status and Future Directions
(CSHP), 45-minute video with 36-page user guide
Joint meeting of the Systemic Advisory Committee and the Inter-Provincial Drug Strategies and Guidelines Working Group
CAPhO Report
February 19-20, 2007
Submitted by Lynne Nakashima
December 2010
November 2009
Submitted by Lynne Nakashima
May 14, 2003
Submitted by Gabriel Gazzé
2006
CAPhO Report
September 2002
Submitted by Lynne Nakashima
(ASHP), By Luci Power & James Jorgenson. 2006; Approx. 90 minutes; Softbound (Workbook), DVD
Table outlining USP Chapter <797> Requirement with Joint Commission 2010 Hospital Standards and NPSGs